Vulvovaginal candidiasis and bacterial vaginosis.
Vulvovaginal candidiasis (VVC) and bacterial vaginosis (BV) are frequently encountered in clinical practice. Recent advances have furthered understanding of pathophysiology. Proper diagnosis, based on appropriate office and, in complicated cases, laboratory tests is the key to rational selection of therapy. For women who have routine uncomplicated episodes of VVC or BV, a variety of effective treatment options exists. Recurrent disease remains a challenge for these conditions but can often be managed successfully.
Nyirjesy
Paul
P
Department of Obstetrics and Gynecology, Drexel University College of Medicine, 245 North 15th Street, New College Building, 16th Floor, Philadelphia, PA 19102, USA. Electronic address: 19102.pnyirjes@drexelmed.edu.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002181:Candidiasis, Vulvovaginal / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology / Q000503:physiopathology; D005260:Female; D006801:Humans; D016585:Vaginosis, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology / Q000503:physiopathology
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents